Skip to content

Scholar Rock SRRK Total Current Assets

Total Current Assets at other companies

Biogen logo
BiogenBIIB
$9.19B+20.5%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$509.79M+15.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.25B-2.7%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$1.02B+48.1%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$940.39M+37.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$877.8M+247%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's total current assets?
Scholar Rock (SRRK) reported total current assets of $515.28M in Q1 2026.
How has Scholar Rock's total current assets changed year-over-year?
Scholar Rock's total current assets increased by 33.8% year-over-year, from $385.25M to $515.28M.
What is the long-term trend for Scholar Rock's total current assets?
Over 5 years (2020 to 2025), Scholar Rock's total current assets has grown at a 2.3% compound annual growth rate (CAGR), from $344.4M to $385.15M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.